GUT MICROBIAL METABOLISM OF 5-ASA DIMINISHES ITS CLINICAL EFFICACY IN IBD

被引：0
|
作者：
Mehta, Raaj S.
Mayers, Jared
Glasser, Nathaniel
Zhang, Yancong
Bhosle, Amrisha
Nguyen, Long H.
Ma, Wenjie
Bae, Sena
Branck, Tobyn
Ananthakrishnan, Ashwin
Franzosa, Eric A.
Balskus, Emily
Chan, Andrew
Huttenhower, Curtis
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
549
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [31] Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease
    Sonu, Irene
    Lin, Ming Valerie
    Blonski, Wojciech
    Lichtenstein, Gary R.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2010, 39 (03) : 559 - +
  • [32] Efficacy of 5-ASA in the Treatment of Colonic Diverticular Disease: A Systematic Review
    Gatta, Luigi
    Vakil, Nimish B.
    Vaira, Dino
    Pilotto, Alberto
    Curlo, M.
    Comparato, G.
    Leandro, Gioacchino
    Ferro, Umberto
    Lera, Maurizio
    Milletti, Sergio
    Di Mario, Francesco
    GASTROENTEROLOGY, 2009, 136 (05) : A684 - A684
  • [33] Long-term 5-ASA treatment and gender-related differences in children with IBD
    Hadziselimovic, F
    Widauer, JO
    Emmons, LR
    AUTOIMMUNE DISEASES IN PEDIATRIC GASTROENTEROLOGY, 2002, 127 : 159 - 163
  • [34] A population based study of patterns of 5-ASA drug use among IBD patients.
    Bernstein, CN
    Metge, C
    Blanchard, JF
    Peterson, S
    GASTROENTEROLOGY, 2000, 118 (04) : A116 - A116
  • [35] Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice
    Romkens, Tessa E. H.
    te Morsche, Rene
    Peters, Wilbert
    Burger, David M.
    Hoentjen, Frank
    Drenth, Joost P. H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (03) : 477 - 481
  • [36] 5-ASA is Not Chemoprotective for Colorectal Cancer in IBD: A Meta-Analysis of Population-Based Studies
    Gulamhusein, Aliya
    Bernstein, Charles N.
    Nguyen, Geoffrey C.
    GASTROENTEROLOGY, 2011, 140 (05) : S64 - S65
  • [37] Clinical predictors of a frequently relapsing disease course under 5-ASA amongst ulcerative colitis patients initially responding to induction therapy with 5-ASA and/or steroids
    Atay, K.
    Erzin, Y.
    Hatemi, I.
    Eskazan, T.
    Serin, I.
    Bozcan, S.
    Demir, N.
    Celik, A. F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S223 - S224
  • [38] 5-aminosalicylic acid (5-ASA) therapy is associated with renal failure in patients with inflammatory bowel disease (IBD).
    Elseviers, MM
    Nouwen, EJ
    DeBroe, ME
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0590 - A0590
  • [39] Reconsider the fluorescence properties of 5-ASA and its sensing mechanism for iodide ion
    Liu, Lei
    Sun, Bingqing
    Pen, Jiancheng
    Mao, Yueyuan
    Ding, Ran
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2019, 223
  • [40] Baseline gut microbiota composition and function reflect response to 5-ASA treatment in Ulcerative Colitis
    Radhakrishnan, S. T.
    Alexander, J. L.
    Mullish, B. H.
    Danckert, N. P.
    Valdivia-Garcia, M. A.
    Serrano-Contreras, J. I.
    Balarajah, S.
    Perry, R.
    Gallagher, K. I.
    Hicks, L. C.
    Powell, N.
    Li, J. V.
    Marchesi, J. R.
    Williams, H. R. T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2138 - I2138
12345